Global Breast Lesion Localization Methods Market - 2024-2031

Overview

Global Breast Lesion Localization Market reached US$ 363.87 million in 2023 and is expected to reach US$ 795.15 million by 2031, growing at a CAGR of 10.5% during the forecast period 2024-2031.

Breast lesion localization methods are pre-surgical procedures, where localization devices such as radioisotopes, magnetic tracers, and wires are inserted into cancer-detected sites to localize a non-palpable lesion at the time of surgical excision.

Breast Lesion Localization Methods procedure is carried out using surgical guidance systems such as ultrasound, Magnetic Resonance Imaging (MRI), or mammography, depending on the type of lesion and its location. With earlier detection of breast lesions, localization procedures have become necessary in up to 50% of all lumpectomy and surgical biopsy procedures to ensure accurate removal of the target lesion.

Market Dynamics: Drivers & Restraints

Increasing incidence of breast cancer

The increasing incidences of breast cancer among women are the predominant driving factor of the global market for breast lesion localization methods. The localization step ensures that the surgeon can accurately identify and excise the lesion during the surgery.

For instance, according to the World Cancer Research Fund International, it is stated that there were 2,296,840 new cases of breast cancer in 2022 among women.

Every country contains a large number of breast cancer patients which is raising the need for localization. For instance, China accounts for over 357,161 individuals suffering from breast cancer and the U.S. accounts for almost 274, 375 individuals with breast cancer. Thus, the increasing number of individuals with breast cancer could raise the market growth.

High cost of advanced technologies

Advanced localization approaches, such as radioactive seed localization (RSL) and magnetic seed localization (MSL), often require the use of costly specialized equipment. Beyond the initial investment, these technologies may necessitate ongoing maintenance, specialized equipment, and materials, which increases the entire cost. This may cause a financial burden on healthcare providers.

Market Segment Analysis

The global breast lesion localization market is segmented based on method, devices and region.

Wire-Guided Localization (WGL) segment is expected to dominate the market share

The wire-guided localization share holds the most significant market share and is expected to remain dominant over the forecast period. It can be attributed to its early establishment and higher adoption rate among end-users. This localization provides precise localization of lesions, especially lesions that are tiny or difficult to visualize using other methods.

Wire-guided localization is a well-established and commonly used approach for directing breast surgery, with a long history of success. The procedure is well-regulated and has a high safety and efficacy profile, which helps to ensure its continued use and adoption. Thus, the above factors are expected to hold the segment in the market share.

Market Geographical Share

North America is expected to hold a significant position in the breast lesion localization market share

North America holds a substantial share of the global breast lesion localization methods market, and it is primarily attributed to factors such as the high prevalence of breast cancer in the region. It has a broad base of the patient population and the presence of significant medical companies.

Moreover, the higher awareness in developed areas such as the U.S., high healthcare expenditure, the presence of research facilities and labs, the extensive research activities undertaken by a majority of prominent players in the area, and the early adoption of advanced medical technologies help propel the regional market.

For instance, according to the Centers for Disease Control and Prevention report in 2022, 272,454 new breast cancers were reported in females in 2021, and in 2022, 42,211 females died from breast cancer.

Additionally, according to the American Cancer Society, Inc., it is estimated that about 310,720 new cases of invasive breast cancer will be diagnosed in women in 2024, and about 56,500 new cases of ductal carcinoma in situ (DCIS) will be diagnosed. Thus, the increasing number of breast cancer cases is expected to increase the demand for localization methods, thus holding the region in the dominant position.

Market Segmentation

By Method

Wire-Guided Localization (WGL)

Magnetic Tracers

Electromagnetic Reflectors

Radio Guided Occult-Lesion Localization (ROLL)

Radioactive-Seed Localization (RSL)

Others

Breast Biopsy Marker Localization

Others

By Devices

Radioactive Seeds

Radar Reflectors

Magnetic Seeds

Radiofrequency Identification Tag Localizers (RFIDs)

Wires

Coils

Others

By Region

North America

The U.S.

Canada

Mexico

Europe

Germany

UK

France

Italy

Spain

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the market include Becton, Dickinson, and Company, Sterylab S.r.l., SOMATEX Medical Technologies GmbH, Argon Medical Devices, Hologic Inc., Cook Medical, Mammotome, Merit Medical Systems, Inc., Theragenics Corporation and Mermaid Medical among others.

Why Purchase the Report?

To visualize the global breast lesion localization market segmentation based on type, drug type, route of administration, distribution channel, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of breast lesion localization market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global breast lesion localization market report would provide approximately 53 tables, 47 figures, and 176 pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies